Rosamund Hill: Neurologist on the new anti-migraine medication costing kiwis $300 a month

Early Edition on Newstalk ZB

Content provided by NZME and Newstalk ZB. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by NZME and Newstalk ZB or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

1M ago 4:53

MP3•Episode home

New and effective anti-migraine drugs aren't publicly funded in New Zealand, costing those with chronic migraine nearly $300 a month.

An Otago University survey suggests almost half of those with the disease meet the criteria for severe disability.

Some report paralysis on one side of the body and loss of coherent speech.

Neurologist Rosamund Hill told Mike Hosking that the medicine's publicly funded in Australia.

She says it's feasible for Pharmac to identify those at the worst end of the spectrum, and how these drugs would significantly change their lives.

LISTEN ABOVE

See omnystudio.com/listener for privacy information.

2665 episodes

#New Zealand Current Affairs #NZME #Newstalk ZB #News #New Zealand